Lei Chen, Ph.D., co-founder of Rarity Bioscience AB speaks about SafeLock assays on Uppsala University News

december 7, 2021

Lei Chen, Ph.D., co-founder of Rarity Bioscience AB speaks about SafeLock assays on Uppsala University News.

https://www.uu.se/nyheter/artikel/?id=17872&typ=artikel&lang=sv

(Text in Swedish)

Share this article

Recommended articles

Best Poster Award 2022 at European Society for Medical Oncology

CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen

Rarity: Prestigious Skapa innovation Award winner 2022

We are delighted to share that Dr. Lei Chen has

superRCA published in Nature Communications

With an innovative, super sensitive technology, so-called superRCA, remaining cancer

Follow us

Sitemap

Contact us